Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.

Wanandi, Septelia Inawati; Limanto, Agus; Yunita, Elvira; Syahrani, Resda Akhra; Louisa, Melva; Wibowo, Agung Eru; Arumsari, Sekar · PLoS One · 2021

Where this comes from

Record sourced from PubMed, PMID 33621270.
Also identified by DOI 10.1371/journal.pone.0247694 and PMC identifier 7901776.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0240020.].

Read the full text

View on PubMed · Publisher (DOI)